Quantcast
Connect with us

Defying ‘logic and the law,’ HHS inspector general allows Trump’s vaccine czar to maintain big pharma investments

Published

on

Moncef Slaoui (Screen Capture)

Ethics watchdogs on Wednesday slammed a ruling by the Health and Human Services Department’s inspector general, who decided this week that Moncef Slaoui, a former pharmaceutical executive now heading the Trump administration’s coronavirus vaccine task force, does not have to disclose or divest his investments in the industry.

As the co-director of Operation Warp Speed, a public-private partnership aimed at finding a vaccine for Covid-19 by the end of 2020, Slaoui is in the position to award contracts to pharmaceutical companies researching potential vaccines and treatments.

ADVERTISEMENT

As Common Dreams reported in May when Slaoui was appointed and designated a “volunteer contractor” by the Trump administration, the former head of GlaxoSmithKline’s (GSK) vaccines department continues to hold stock in the company, even as it is collaborating with Sanofi on a potential vaccine.

“We oppose this kind of corruption and blatant conflict of interest,” said the healthcare coalition Lower Drug Prices Now in response to the ruling.

The ruling by the HHS Office of the Inspector General (OIG) came in response to an ethics complaint filed in May by Public Citizen and Lower Drug Prices Now. According to the Washington Post, the organizations said in their complaint that there is “no basis in law for Slaoui to run Operation Warp Speed without being a full-time government employee” or a “special government employee,” two designations that would require him to disclose and divest his financial interests.

ADVERTISEMENT

The “special government employee” designation is given to professionals who temporarily join administration projects for a maximum of 130 days. In its response to the complaint, the OIG reportedly focused mainly on the fact that Slaoui will be in his position for longer than 130 days, but did not address the groups’ concerns about conflicts of interest.

Public Citizen expressed dismay that the OIG didn’t recognize Slaoui’s conflict of interest in its ruling on Monday.

“What few public records we have show that Slaoui does indeed hold financial interests in some of the vaccine companies being awarded government contracts under Warp Speed,” Craig Holman, a government affairs lobbyist for Public Citizen, told Common Dreams on Wednesday. “But we do not know how deep these conflicts of interest run because Slaoui is not even required to disclose the extent of his holdings. The IG has given a green light for Slaoui to use his public office for self-enrichment, a practice that has become frighteningly common within the Trump administration.”

ADVERTISEMENT

The OIG is currently headed by Christi Grimm, who drew President Donald Trump’s ire after releasing a report detailing shortages of medical supplies to respond to the coronavirus pandemic.

“The rationale for the dismissal is tortured at best and reflects that the ‘independent’ IG seems to feel intimidated by Trump and has chosen to sidestep a confrontation,” Holman said.

ADVERTISEMENT

In addition to holding $10 million in stock in GSK as of May, Slaoui held an unknown number of shares in the company when he took the Operation Warp Speed position. He told the New York Times at the time that the shares were his “retirement.”

“What I said regarding the GSK shares, I said I cannot take the job if I have to sell them,” Slaoui told the Times.

Slaoui is also chairman of the board of research company Vaxcyte. The company has received investment from Medicxi, a venture capital firm from which Slaoui is currently on hiatus as a partner.

ADVERTISEMENT

“The IG’s decision allows Slaoui to continue working as a private contractor running the nation’s largest government program, which defies logic and the law,” Holman told Common Dreams. “He is free to hold and acquire financial interests in the same vaccine companies to which he is helping award government contracts. This casts a pall of potential favoritism and self-dealing in every decision Slaoui makes on behalf of Operation Warp Speed.”


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Asymptomatic coronaagvirus sufferers lose antibodies sooner: study

Published

on

Asymptomatic coronavirus sufferers appear to lose detectable antibodies sooner than people who have exhibited Covid-19 symptoms, according to one of the biggest studies of its kind in Britain published on Tuesday.

The findings by Imperial College London and market research firm Ipsos Mori also suggest the loss of antibodies was slower in 18–24 year-olds compared to those aged 75 and over.

Overall, samples from hundreds of thousands of people across England between mid-June and late September showed the prevalence of virus antibodies fell by more than a quarter.

The research, commissioned by the British government and published Tuesday by Imperial, indicates people's immune response to Covid-19 reduces over time following infection.

Continue Reading

Breaking Banner

Brett Kavanaugh caught lying in SCOTUS opinion against voting access during the pandemic: report

Published

on

Supreme Court Justice Brett Kavanaugh on Monday voted that 2020 elections ballots in Wisconsin can only be counted if received by Election Day.

Kavanaugh issued his own concurring opinion, where he suggested that state courts should be barred from protecting voting rights.

Kavanaugh also made a mistake of fact.

Sam Levine, a voting rights reporter for the Guardian, noted Kavanaugh was inaccurate in his concurring opinion.

Continue Reading
 

COVID-19

COVID-19 causes some patients’ immune systems to attack their own bodies — and can worsen the illness

Published

on

Across the world, immunologists who retooled their labs to join the fight against SARS-CoV-2 are furiously trying to explain why some people get so sick while others recover unscathed. The pace is dizzying, but some clear trends have emerged.

One area of focus has been the production of antibodies – powerful proteins capable of disabling and killing invading pathogens like viruses. Of great concern has been the sporadic identification of so-called autoreactive antibodies that, instead of targeting disease causing microbes, target the tissues of individuals suffering from severe cases of COVID-19.

Continue Reading
 
 
Democracy is in peril. Invest in progressive news. Join Raw Story Investigates for $1. Go ad-free. LEARN MORE